Measles elimination: progress and challenges (Q33772449)

29 July 2017

1 reference

title

Measles elimination: progress and challenges (English)

1 reference

29 July 2017

1 reference

Cutts FT

1

1 reference

29 July 2017

Henao-Restrepo A

series ordinal

2

1 reference

29 July 2017

Olivé JM

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

29 July 2017

1 reference

29 July 2017

17 Suppl 3

1 reference

29 July 2017

S47-52

1 reference

Should measles be eradicated?

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Herd immunity: history, theory, practice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

No measles in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Measles elimination in the Americas. Evolving strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Immunization in the developing world: strategic challenges.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Implications of the human immunodeficiency virus epidemic for control and eradication of measles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Measles case fatality by sex, vaccination status, and HIV-1 antibody in Zambian children.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Increased risk of early measles in infants of human immunodeficiency virus type 1-seropositive mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Fatal Measles Pneumonia Without Rash in a Child with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Persistent measles infection in malnourished children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Safety and immunogenicity of high-dose Edmonston-Zagreb measles vaccine in children with HIV-1 infection. A cohort study in Kigali, Rwanda.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Immunogenicity of high-titer Edmonston-Zagreb measles vaccine in human immunodeficiency virus-infected children in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Measles epidemic in the urban community of Niamey: transmission patterns, vaccine efficacy and immunization strategies, Niger, 1990 to 1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Measles control in young infants: where do we go from here?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Alternative routes of measles immunization: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Measles antibody: reevaluation of protective titers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Measles vaccine effectiveness and duration of vaccine-induced immunity in the absence of boosting from exposure to measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

The case for global measles eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900309-6

7 January 2021

10.1016/S0264-410X(99)00309-6

Identifiers

DOI

1 reference

29 July 2017

1 reference